3rd annual OTC Derivatives Operations in Fund Management

Venue: London

Location: London, United Kingdom

Event Date/Time: Nov 27, 2007 End Date/Time: Nov 28, 2007
Report as Spam


Now in its 3rd year, this prestigious event is designed for the industry leaders who set the overall strategy for OTC derivatives operations and technology. The event will attract the most senior stakeholders from the buy-side, sell-side and technology providers to undertake holistic analysis of how companies – buy-side in particular - can unleash the potential of OTC Derivatives instruments through streamlined settlement processes.

By attending this event, you will benefit from a fabulous networking forum and an excellent programme drawn from the operational experience of our international speaker panel. You will:

- Discover the true impact of OTC Derivatives on enterprise-wide data management
- Hear how to create an infrastructure that provides a scalable level of support required for the influx of novel and bespoke instruments
- Learn how your peers are dealing with pricing and collateral management and take home techniques that will allow you to apply this to your own operations
- Explore the possibility, viability and current situation with end-to-end STP and the solutions available to realise your competitive advantage
- Debate your key technological concerns and unmet needs directly with your solution providers in a unique panel session
- And much more! Not only that, but Osney Media’s roundtable events are renowned as truly innovative, interactive and informative experiences.

The programme will be led by organisations such as ABN AMRO Asset Management * Morley Fund Management * DTCC * Swapswire * Barclays Capital * Lehman Brothers * JPMorgan Worldwide Securities Services * BNP Paribas Securities Services * Citigroup and many others.

This is your opportunity to review the way your organisation operates, improve your efficiency, maintain your competitiveness and find out how to achieve a streamlined settlement process for OTC products.